Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2025-12-28 @ 4:53 PM
Study NCT ID:
NCT02600468
Status:
COMPLETED
Last Update Posted:
2017-01-16
First Post:
2015-11-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Survey on Long-Term Use of ORENCIA® Intravenous Infusion 250mg
Sponsor:
Bristol-Myers Squibb
Organization:
Study Overview
Official Title:
Outline of Survey on Long-Term Use of ORENCIA® Intravenous Infusion 250mg
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study to collect information on the safety, especially serious infections and malignancies, and efficacy of the long-term use of ORENCIA Intravenous Infusion 250mg in patients with rheumatoid arthritis.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: